Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticlePersonalizing Cancer Therapy with FDG PET: From RECIST to PERCIST

18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer

Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
Journal of Nuclear Medicine May 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232
Bernd J. Krause
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hinrich Wieder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Meyer zum Büschenfelde
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 50 no. Suppl 1 89S-96S
DOI 
https://doi.org/10.2967/jnumed.108.057232
PubMed 
19380406

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication November 24, 2008
  • Accepted for publication February 9, 2009
  • Published online April 29, 2009.

Article Versions

  • previous version (April 20, 2009 - 05:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Bernd J. Krause 1 ,
  2. Ken Herrmann 1 ,
  3. Hinrich Wieder 2 and
  4. Christian Meyer zum Büschenfelde 3
  1. 1Department of Nuclear Medicine, Technische Universität München, Munich, Germany; 2Department of Radiology, Technische Universität München, Munich, Germany; and 3Department of Internal Medicine, Technische Universität München, Munich, Germany
  1. For correspondence or reprints contact: Bernd Joachim Krause, Department of Nuclear Medicine, Klinikum rechts der Isar Technische Universität München, Ismaninger Str. 22, 81675 München, Germany. E-mail: Bernd-Joachim.Krause{at}tum.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 60 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
    Florent Tixier, Catherine Cheze Le Rest, Mathieu Hatt, Nidal Albarghach, Olivier Pradier, Jean-Philippe Metges, Laurent Corcos, Dimitris Visvikis
    Journal of Nuclear Medicine 2011 52 3
  • Positron Emission Tomography (PET) in Oncology
    Andrea Gallamini, Colette Zwarthoed, Anna Borra
    Cancers 2014 6 4
  • Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
    Elizabeth C. Smyth, Matteo Fassan, David Cunningham, William H. Allum, Alicia F.C. Okines, Andrea Lampis, Jens C. Hahne, Massimo Rugge, Clare Peckitt, Matthew Nankivell, Ruth Langley, Michele Ghidini, Chiara Braconi, Andrew Wotherspoon, Heike I. Grabsch, Nicola Valeri
    Journal of Clinical Oncology 2016 34 23
  • Assessing Tumor Response to Therapy
    Wolfgang A. Weber
    Journal of Nuclear Medicine 2009 50 Suppl 1
  • PET/CT imaging in cancer: Current applications and future directions
    Michael D. Farwell, Daniel A. Pryma, David A. Mankoff
    Cancer 2014 120 22
  • Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer
    M Kranzfelder, T Schuster, H Geinitz, H Friess, P Büchler
    British Journal of Surgery 2011 98 6
  • Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
    Adrianus J. de Langen, Andrew Vincent, Linda M. Velasquez, Harm van Tinteren, Ronald Boellaard, Lalitha K. Shankar, Maarten Boers, Egbert F. Smit, Sigrid Stroobants, Wolfgang A. Weber, Otto S. Hoekstra
    Journal of Nuclear Medicine 2012 53 5
  • Modeling Pathologic Response of Esophageal Cancer to Chemoradiation Therapy Using Spatial-Temporal 18F-FDG PET Features, Clinical Parameters, and Demographics
    Hao Zhang, Shan Tan, Wengen Chen, Seth Kligerman, Grace Kim, Warren D. D'Souza, Mohan Suntharalingam, Wei Lu
    International Journal of Radiation Oncology*Biology*Physics 2014 88 1
  • Molecular imaging in cancer treatment
    Mark H. Michalski, Xiaoyuan Chen
    European Journal of Nuclear Medicine and Molecular Imaging 2011 38 2
  • Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer
    Mathieu Hatt, Dimitris Visvikis, Olivier Pradier, Catherine Cheze-le Rest
    European Journal of Nuclear Medicine and Molecular Imaging 2011 38 9

Article usage

Article usage: April 2009 to April 2025

AbstractFullPdf
Apr 200942565
May 20097333212
Jun 20095230124
Jul 2009453099
Aug 2009304883
Sep 2009324272
Oct 2009516878
Nov 20093192120
Dec 2009217284
Jan 2010208780
Feb 2010267997
Mar 20103511696
Apr 20104911872
May 2010386081
Jun 2010255261
Jul 2010214341
Aug 2010257859
Sep 2010295765
Oct 2010154738
Nov 2010136557
Dec 2010137256
Jan 2011196959
Feb 2011114934
Mar 2011256969
Apr 2011214940
May 201194942
Jun 2011774350
Jul 2011544039
Aug 2011895557
Sep 2011863440
Oct 2011835944
Nov 2011723844
Dec 2011632746
Jan 2012753035
Feb 2012993140
Mar 2012993438
Apr 2012963643
May 20121033834
Jun 2012882142
Jul 2012732533
Aug 2012832722
Sep 2012693932
Oct 2012762231
Nov 2012734944
Dec 2012672630
Jan 2013704425
Feb 2013773938
Mar 2013543739
Apr 2013931847
May 2013713329
Jun 201355940
Jul 201334529
Aug 2013611439
Sep 201358621
Oct 2013511032
Nov 2013581539
Dec 2013351039
Jan 2014391949
Feb 2014341340
Mar 2014471741
Apr 2014421851
May 2014351446
Jun 2014311836
Jul 2014432342
Aug 2014371735
Sep 2014151928
Oct 2014452210
Nov 2014402619
Dec 201427149
Jan 201523235
Feb 2015312512
Mar 2015465416
Apr 2015292720
May 2015422715
Jun 201537246
Jul 2015232923
Aug 2015262516
Sep 2015202210
Oct 2015271827
Nov 2015332114
Dec 201548218
Jan 2016702612
Feb 2016562311
Mar 2016182219
Apr 201691511
May 2016172413
Jun 2016283818
Jul 2016223131
Aug 2016152324
Sep 2016262314
Oct 2016272218
Nov 2016212213
Dec 201615268
Jan 201721259
Feb 2017132410
Mar 201714279
Apr 20179413
May 2017252910
Jun 201720266
Jul 201719278
Aug 2017242212
Sep 2017172311
Oct 2017282713
Nov 201718257
Dec 201718248
Jan 201819106
Feb 201819145
Mar 20181598
Apr 201820125
May 201817118
Jun 20189194
Jul 201811102
Aug 2018782
Sep 20189113
Oct 20186225
Nov 2018691
Dec 20185145
Jan 201910132
Feb 20193183
Mar 20197154
Apr 201961812
May 201911128
Jun 2019834
Jul 2019596
Aug 20198186
Sep 2019524
Oct 2019969
Nov 20199310
Dec 2019515
Jan 2020532
Feb 2020954
Mar 2020854
Apr 2020284
May 20205126
Jun 2020555
Jul 2020613
Aug 2020524
Sep 20201446
Oct 20201868
Nov 202010135
Dec 20206154
Jan 202111716
Feb 202193620
Mar 202162511
Apr 20214288
May 202163919
Jun 20218295
Jul 202153014
Aug 202144115
Sep 202142917
Oct 202142927
Nov 202163026
Dec 202122611
Jan 20223248
Feb 202264010
Mar 202252621
Apr 202242818
May 202242824
Jun 2022101615
Jul 20224198
Aug 20223126
Sep 202233927
Oct 202271920
Nov 202252614
Dec 202272815
Jan 202386228
Feb 20234275
Mar 202374723
Apr 20238316
May 202392513
Jun 202343911
Jul 20234306
Aug 202333915
Sep 20239515
Oct 202377416
Nov 202325621
Dec 2023168316
Jan 2024246720
Feb 2024184918
Mar 202494842
Apr 2024712025
May 2024716420
Jun 20244528
Jul 202446417
Aug 2024105922
Sep 2024510420
Oct 202464816
Nov 202476228
Dec 202437514
Jan 202555518
Feb 2025812918
Mar 202569320
Apr 2025311325
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (Suppl 1)
Journal of Nuclear Medicine
Vol. 50, Issue Suppl 1
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
Bernd J. Krause, Ken Herrmann, Hinrich Wieder, Christian Meyer zum Büschenfelde
Journal of Nuclear Medicine May 2009, 50 (Suppl 1) 89S-96S; DOI: 10.2967/jnumed.108.057232

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
Bernd J. Krause, Ken Herrmann, Hinrich Wieder, Christian Meyer zum Büschenfelde
Journal of Nuclear Medicine May 2009, 50 (Suppl 1) 89S-96S; DOI: 10.2967/jnumed.108.057232
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • ASSESSMENT OF RESPONSE LATE IN THERAPY
    • ASSESSMENT OF RESPONSE EARLY IN THERAPY
    • CONCLUSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
  • Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
  • Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
  • Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the Esophagus
  • Assessing Tumor Response to Therapy
  • Google Scholar

More in this TOC Section

  • PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
  • Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
Show more Personalizing Cancer Therapy with FDG PET: From RECIST to PERCIST

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire